As The Carlyle Group prepares to release its quarterly earnings, the private equity firm finds itself navigating a complex landscape of billion-dollar strategic moves and growing market skepticism. Recent weeks have seen the financial investor execute a landmark chemical sector acquisition while simultaneously facing downgraded analyst ratings, creating uncertainty about whether the firm is positioning for a turnaround or facing further challenges.
Upcoming Earnings to Set Direction
All eyes turn to Friday, October 31, when Carlyle is scheduled to announce its third-quarter 2025 financial results before market opening. Market experts project earnings of $1.02 per share with revenue approximating $1 billion.
The 8:30 AM Eastern Time conference call will likely serve as a crucial indicator of the firm’s strategic direction. Investors are anticipating detailed explanations regarding the rationale behind recent portfolio moves, fundraising prospects, and performance metrics across Carlyle’s investment holdings. With private equity firms currently confronting rising interest rates and shifting market dynamics, the upcoming report carries significant weight for Carlyle’s near-term trajectory.
Strategic Moves Reshape Portfolio
Carlyle’s most notable recent transaction involves its agreement to acquire a majority stake in BASF’s coatings business for €7.7 billion. This high-profile chemical sector acquisition, viewed as a landmark deal within the industry, highlights Carlyle’s continued emphasis on industrial assets with robust cash flow generation. Under the arrangement, BASF will retain 40 percent ownership and receive approximately €5.8 billion in cash when the transaction finalizes in the second quarter of 2026, pending regulatory approvals.
Should investors sell immediately? Or is it worth buying The Carlyle Group?
Concurrently, the firm continues restructuring its investment portfolio. On October 24, Carlyle divested its majority stake in Italian motorcycle gear and sportswear manufacturer Dainese to Arcmont Asset Management and HPS Investment Partners. This disposal forms part of broader financial restructuring efforts for the indebted company.
Market Analysts Express Caution
Despite these strategic repositioning efforts, warning signals have emerged from market observers. The Wolf Report downgraded Carlyle shares to “Hold” on Monday, citing constrained upside potential due to elevated valuations, persistent market volatility, and a crowded financial sector.
This cautious assessment arrives at a pivotal moment for the stock, which currently trades approximately 16 percent below its 52-week high while encountering significant resistance levels. Technical indicators further reinforce analyst concerns, with an RSI reading exceeding 75 suggesting overbought conditions.
The fundamental question remains whether Carlyle can leverage strong quarterly results to counter skeptical market voices and validate its recent strategic decisions. Friday’s earnings release may well establish the directional course for the coming months.
Ad
The Carlyle Group Stock: Buy or Sell?! New The Carlyle Group Analysis from October 28 delivers the answer:
The latest The Carlyle Group figures speak for themselves: Urgent action needed for The Carlyle Group investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 28.
The Carlyle Group: Buy or sell? Read more here...









